Roche's 2009 MDx Sales Rise 2 Percent; Applied Science Sales up 12 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today reported that full-year 2009 sales of its molecular diagnostic products rose 2 percent to CHF 1.18 billion ($1.11 billion).

The Swiss drugs, diagnostics, and life science research products firm said that its molecular diagnostics' core blood screening and virology segments "delivered a solid single-digit rise in overall sales."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.